Pathways of Thyroid Hormone Metabolism

Acta Medica Austriaca

Volumn 23, Issue 1-2, 1996, Pages 10-16

  Visser, T J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Conjugation; Deiodination; Glucuronidation; Iodothyronine deiodinases; Iodothyronines; Reverse triiodothyronine (rT3); Sulfation; Tetrac (TA4); Thyroid hormone; Thyroxine (T4); Triac (TA3); Triiodothyronine (T3)

Indexed keywords

3 IODOTHYRONINE; 3,3',5' TRIIODOTHYRONINE; 3-MONOIODOTHYRONINE; GLUCURONOSYLTRANSFERASE; IODIDE PEROXIDASE; IODINE; LIOTHYRONINE; SULFOTRANSFERASE; THYROID HORMONE; THYRONINE DERIVATIVE; THYROXINE;

ANIMAL; ANTIBODY SPECIFICITY; BILE; ENZYMOLOGY; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALS; BILE; GLUCURONOSYLTRANSFERASE; HUMANS; IODIDE PEROXIDASE; IODINE; ORGAN SPECIFICITY; SULFOTRANSFERASES; THYROID HORMONES; THYRONINES; THYROXINE; TRIIODOTHYRONINE; TRIIODOTHYRONINE, REVERSE;

EID: 0029705444     PISSN: 03038173     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (83)

1. Engler D, Burger AG: The deiodination of iodothyronines and their derivatives in man. Endocr Rev 1984;5:151-184.
2. Leonard JL, Visser TJ: Biochemistry of deiodination, in Hennemann G (ed): Thyroid Hormone Metabolism. Marcel Dekker, New York, 1986, pp 189-229.
3. Köhrle J, Hesch RD, Leonard JL: Intracellular pathways of iodothyronine metabolism, in Braverman LE, Utiger RD (eds): The Thyroid. Philadelphia, Lippincott, 1991, pp 144-189.
4. Larsen PR, Berry MJ: Nutritional and hormonal regulation of thyroid hormone deiodinases. Ann Rev Nutr 1995;15:323-352.
5. Visser TJ: Sulfation and glucuronidation pathways of thyroid hormone metabolism, in Wu SY, Visser TJ (eds): Thyroid hormone metabolism: Molecular biology and alternate pathways. Baco Raton, CRC Press, 1994, pp 85-117.
6. Green WL: Ether-link cleavage of iodothyronines, in Wu SY, Visser TJ (eds): Thyroid hormone metabolism: Molecular biology and alternate pathways. Baco Raton, CRC Press, 1994, pp 199-221.
7. Siegrist-Kaiser CA, Burger AG: Modification of the side chain of thyroid hormone, in Wu SY, Visser TJ (eds): Thyroid hormone metabolism: Molecular biology and alternate pathways. Baco Raton, CRC Press, 1994, pp 175-198.
8. Berry MJ, Banu L, Larsen PR: Type I iodothyronine deiodinase is a selenocysteine-containing enzyme. Nature 1991;349:438-440.
9. Mandel SJ, Berry MJ, Kieffer JD, Harney JW, Warne RL, Larsen PR: Cloning and in vitro expression of the human selenoprotein, type I iodothyronine deiodinase. J Clin Endocrinol Metab 1992;75:1133-1139.
10. Toyoda N, Harney JW, Berry MJ, Larsen PR: Identification of critical amino acids for 3,3′,5′-triiodothyronine deiodination by human type I deiodinase based on comparative functional-structural analyses of the human, dogand rat enzymes. J Biol Chem 1995;269:20329-20334.
11. Maia AL, Berry MJ, Sabbag R, Harney JW, Larsen PR: Structural and functional differences in the diol gene in mice with inherited type I deiodinase deficiency. Mol Endocrinol 1995;9:969-980.
12. St.Germain DL, Schwartzman RA, Croteau W, Kanamori A, Wang Z, Brown DD, Galton VA: A thyroid hormone-regulated gene in Xenopus laevis encodes a type III iodothyronine 5-deiodinase. Proc Natl Acad Sci USA 1994;91:7767-7771,11282.
13. Becker KB, Schneider MJ, Davey JC, Galton VA: The type III 5-deiodinase in Rana catesbeiana tadpoles is encoded by a thyroid hormone-responsive gene. Endocrinology 1995;136:4424-4431.
14. Croteau W, Whittemore SL, Schneider MJ St.Germain DL: Cloning and expression of a cDNA for a mammalian type III iodothyronine deiodinase. J Biol Chem 1995;270:16569-16575.
15. Salvatore D, Low SC, Berry MJ, Maia AL, Harney JW, Croteau W, St.Germain DL, Larsen, PR: Type 3 iodothyronine deiodinase: cloning, in vitro expression, and functional analysis of the placental selenoenzyme. J Clin Invest 1995;96:2421-2430.
16. Davey JC, Becker KB, Schneider MJ, St.Germain DL, Galton VA. Cloning of a cDNA for the type II iodothyronine deiodinase. J Biol Chem 1995;270:26786-26789.
17. Berry MJ, Larsen PR: Molecular structure and biochemistry of type I iodothyronine deiodinase, in Wu SY, Visser TJ (eds): Thyroid hormone metabolism: Molecular biology and alternate pathways. Baco Raton, CRC Press, 1994, pp 1-21.
18. O'Mara BA, Dittrich W, Lauterio TJ, St.Germain DL: Pretranslational regulation of type I 5′-deiodinase by thyroid hormones and in fasted and diabetic rats. Endocrinology 1993;133:1715-1723.
19. Toyoda N, Nishikawa M, Horimoto M, Yoshikawa N, Mori Y, Yoshimura M, Masaki H, Tanaka K, Inada M: Graves' immunoglobulin G stimulates iodothyronine 5-deiodinating activity in FRTL-5 rat thyroid cells. J Clin Endocrinol Metab 1992;70:1506-1511.
20. Leonard JL, Safran M: Hormonal regulation of type II iodothyronine deiodinase in the brain, in Wu SY, Visser TJ (eds): Thyroid hormone metabolism: Molecular biology and alternate pathways. Baco Raton, CRC Press, 1994, pp 23-44.
21. Halperin Y, Shapiro, LE, Surks MI: Down-regulation of type II L-thyroxine 5′-monodeiodinase in cultured GC cells: different pathways of regulation by L-triiodothyronine and 3,3′,5′-triiodo-L-thyronine. Endocrinology 1994;135: 1464-1469.
22. St.Germain DL: Biochemical Study of type III iodothyronine deiodinase, in Wu SY, Visser TJ (eds): Thyroid hormone metabolism: Molecular biology and alternate pathways. Baco Raton, CRC Press, 1994, pp 45-66.
23. Darras VM, Visser TJ, Berghman LR, Kühn ER: Ontogeny of type I and type III deiodinase activities in embryonic and posthatch chicks: relationship with changes in plasma triiodothyronine and growth hormone levels. Comp Biochem Physiol 1992;103A:131-136.
24. Beckett GJ, Beddows SE, Morrice PC, Nicol F, Arthur JR: Inhibition of hepatic deiodination of thyroxine is caused by selenium deficiency in rats. Biochem J 1987;248:443-447.
25. Beckett GJ, MacDougall DA, Nicol F, Arthur JR: Inhibition of type I and type II iodothyronine deiodinase activity in rat liver, kidney and brain produced by selenium deficiency. Biochem J 1989;259:887-892.
26. Arthur JR, Nicol F, Beckett GJ, Trayhurn P: Impairment of iodothyronine 5′-deiodinase activity in brown adipose tissue and its acute stimulation by cold in selenium deficiency. Can J Physiol Biochem 1991;69:782-785.
27. Meinhold H, Campos-Barros A, Walzog B, Köhler R, Müller F, Behne D: Effects of selenium and iodine deficiency on type I, type II and type III iodothyronine deiodinases and circulating thyroid hormones in the rat. Exp Clin Endocrinol 1993;101:87-93.
28. Chanoine JP, Safran M, Farwell AP, Tranter P, Ekenbarger DM, Dubord S, Alex S, Arthur JR, Beckett GJ, Braverman LE, Leonard JL: Selenium deficiency and type II 5′-deiodinase regulation in the euthyroid and hyperthyroid rat: evidence of a direct effect of thyroxine. Endocrinology 1992;130:479-484.
29. Safran M, Farwell AP, Leonard JL: Evidence that type II 5′deiodinase is not a selenoprotein. J Biol Chem 1991;266:13477-13480.
30. Chanoine JP, Alex S, Stone S, Fang SL, Veronikis I, Leonard JL, Braverman LE: Placental 5-deiodinase activity and fetal thyroid hormone economy are unaffected by selenium deficiency in the rat. Pediat Res 1993;34:288-292.
31. Visser TJ: Recent advances in the characterization of type I iodothyronine deiodinase, in Gordon A, Gross J, Hennemann G (eds): Progress in thyroid research. Rotterdam, Balkema, 1991, pp 27-31.
32. Berry MJ, Maia AL, Kieffer JD, Harney JW, Larsen PR: Substitution of cysteine for selenocysteine in type I iodothyronine deiodinase reduces the catalytic efficiency of the protein but enhances its translation. Endocrinology 1992;131:1848-1852.
33. Berry MJ, Kieffer JD, Harney JW, Larsen PR: Selenocysteine confers the biochemical properties characteristic of the type I iodothyronine deiodinase. J Biol Chem 1991;266:14155-14158.
34. Mol K, Kaptein E, Darras VM, de Greef WJ, Kühn E, Visser TJ: Different thyroid hormone-deiodinating enzymes in tilapia (Oreochromis niloticus) liver and kidney. FEBS Lett 1993;321:140-143.
35. Berry MJ, Kieffer JD, Larsen PR: Evidence that cysteine, not selenocysteine, is the catalytic site of type II iodothyronine deiodinase. Endocrinology 1991;129:550-552.
36. Santini F, Chopra IJ, Hurd RE, Solomon DH, Chua Teco GN: A study of the characteristics of the rat placental iodothyronine 5-monodeiodinase: evidence that it is distinct from the rat hepatic iodothyronine 5′-monodeiodinase. Endocrinology 1992;130:2325-2332.
37. Sharifi J, St.Germain DL: The cDNA for the type I iodothyronine 5′-deiodinase encodes an enzyme manifesting both high Km and low Km activity. J Biol Chem 1992;267:12539-12544.
38. Matsui M, Homma H: Biochemistry and molecular biology of drug-metabolizing sulfotransferase. Int J Biochem 1994;26:1237-1246.
39. Anderson RJ. Biochemical characterization of triiodothyronine sulfotransferase (T3-ST), in Wu SY, Visser TJ (eds): Thyroid hormone metabolism: Molecular biology and alternate pathways. Baco Raton, CRC Press, 1994, pp 155-174.
40. Hurd RE, Santini F, Lee B, Naim P, Chopra IJ: A study of the 3,5,3′-triiodothyronine sulfation activity in the adult and the fetal rat. Endocrinology 1993;133:1951-1955.
41. Gong DW, Murayama N, Yamazoe Y, Kato R: Hepatic triiodothyronine sulfation and its regulation by growth hormone and triiodothyronine in rats. J Biochem 1992;112:112-116.
42. Sekura RD, Sato K, Cahnmann HJ, Robbins J, Jakoby WB: Sulfate transfer to thyroid hormones and their analogs by hepatic aryl sulfotransferase. Endocrinology 1981;108:454-456.
43. Young WF, Gorman CA, Weinshilboum RM: Triiodothyronine: a substrate for the thermostable and thermolabile forms of human phenol sulfotransferase. Endocrinology 1988;122:1816-1824.
44. Santini F, Hurd RE, Chopra IJ: A study of metabolism of deaminated and sulfoconjugated iodothyronines by rat placental iodothyronine 5-monodeiodinase. Endocrinology 1992;131:1689-1694.
45. De Herder WW, Bonthuis F, Rutgers M, Otten MH, Hazenberg MP, Visser TJ: Effects of inhibition of type I iodothyronine deiodinase and phenol sulfotransferase on the biliary clearance of triiodothyronine in rats. Endocrinology 1988;122:153-157.
46. Rutgers M, Bonthuis F, De Herder WW, Visser TJ: Accumulation of plasma triiodothyronine sulfate in rats treated with propylthiouracil. J Clin Invest 1987;80:758-762.
47. Eelkman Rooda SJ, Kaptein E, Rutgers M, Visser TJ: Increased plasma 3,5,3′-triiodothyronine sulfate in rats with inhibited type I iodothyronine deiodinase activity, as measured by radioimmunoassay. Endocrinology 1989;124: 740-745.
48. Eelkman Rooda SJ, Van Loon MAC, Bonthuis F, Heusdens FA, Kaptein E, Visser TJ: Effects of iopanoic acid on the metabolism of T3 in rats. Ann Endocrinol 1988;49:182.
49. Eelkman Rooda SJ, Kaptein E, Visser TJ. Serum triiodothyronine sulfate in man measured by radioimmunoassay. J Clin Endocrinol Metab 1989;69:552-556.
50. Chopra IJ, Wu SY, Chua Teco GN, Santini F: A radioimmunoassay of 3,5,3′-triiodothyronine sulfate: studies in thyroidal and nonthyroidal diseases, pregnancy, and neonatal life. J Clin Endocrinol Metab 1992;75:189-194.
51. LoPresti JS, Mizuno L, Nimalysuria A, Anderson KP, Spencer CA, Nicoloff JT: Characteristics of 3,5,3′-triiodothyronine sulfate metabolism in euthyroid man. J Clin Endocrinol Metab 1991;73:703-709.
52. Rutgers M, Pigmans IGAJ, Bonthuis F, Docter R, Visser TJ: Effects of propylthiouracil on the biliary clearance of thyroxine (T4) in rats: decreased excretion of 3,5,3′-triiodothyronine glucuronide and increased excretion of 3,3′,5′-triiodothyronine glucuronide and T4 sulfate. Endocrinology 1989;125: 2175-2186.
53. Wu SY, Huang WS, Polk D, Florsheim WH, Green WL, Fisher DA: Identification of thyroxine sulfate (T4S) in human serum and amniotic fluid by a novel T4S radioimmunoassay. Thyroid 1992;2:101-105.
54. Chopra IJ, Santini F, Hurd RE, Chua Teco GN: A radioimmunoassay for measurement of thyroxine sulfate. J Clin Endocrinol Metab 1993;76:145-150.
55. Wu SY, Huang WS, Polk D, Chen WL, Reviczky A, Williams J, Chopra IJ, Fisher DA: The development of a radioimmunoassay for reverse triiodothyronine sulfate in human serum and amniotic fluid. J Clin Endocrinol Metab 1993;76:1625-1630.
56. Wu SY, Polk DH, Chen WL, Fisher DA, Huang WS, Yee B: A 3,3′-diiodothyronine sulfate cross-reactive compound in serum from pregnant women. J Clin Endocrinol Metab 1994;78:1505-1509.
57. Wu SY, Polk D, Wong S, Reviczky A, Vu R, Fisher DA: Thyroxine sulfate is a major thyroid hormone metabolite and a potential intermediate in the monodeiodination pathways in fetal sheep. Endocrinology 1992;131:1751-1756
58. Wu SY, Polk DH, Huang WS, Reviczky A, Wang K, Fisher DA: Sulfate conjugates of iodothyronines in developing sheep;effect of fetal hypothyroidism. Am J Physiol 1993;265:E115-E120.
59. Wu SY, Polk D, Fisher DA, Huang WS, Reviczky AL, Chen WL: Identification of 3,3′-T2S as a fetal thyroid hormone derivative in maternal urine in sheep. Am J Physiol 1995;268:E33-E39.
60. Spaulding SW: Bioactivities of conjugated iodothyronines, in Wu SY, Visser TJ (eds): Thyroid hormone metabolism: Molecular biology and alternate pathways. CRC Press, Baco Raton, 1994, pp 139-153.
61. Santini F, Chopra IJ, Wu SY, Solomon DH, Chua Teco GN: Metabolism of 3,5,3′-triiodothyronine sulfate by tissues of the fetal rat: a consideration of the role of desulfation of 3,5,3′-triiodothyronine sulfate as a source of T3. Pediat Res 1992;31:541-544.
62. Burchell B, Coughtrie MWH, Jansen PLM: Function and regulation of UDP-glucuronosyltransferase genes in health and disease. Hepatology 1994;20:1622-1630.
63. Curran PG, DeGroot LJ: The effect of hepatic enzyme-inducing drugs on thyroid hormones and the thyroid gland. Endocr Rev 1991;12:135-150.
64. Visser TJ: Importance of deiodination and conjugation in the hepatic metabolism of thyroid hormone, in Greer MA (ed): The thyroid gland. Raven Press, New York, 1990, pp 255-283.
65. McClain RM: The significance of hepatic microsomal enzyme induction and altered thyroid function in rats: implications for thyroid gland neoplasia. Toxicol Pathol 1989;17:294-306.
66. Beetstra JB, Van Engelen JGM, Karels P, Van der Hoek HJ, De Jong M, Docter R, Krenning EP, Hennemann G, Brouwer A, Visser TJ: Thyroxine and 3,3′,5-triiodothyronine are glucuronidated in rat liver by different uridine diphosphate-glucuronyltransferases. Endocrinology 1991;128:741-746.
67. Van Raaij JAGM, Kaptein E, Visser TJ, Van den Berg KJ: Increased glucuronidation of thyroid hormone in hexachlorobenzene-treated rats. Biochem Pharmacol 1993;45:627-631.
68. Visser TJ, Kaptein E, Van Toor H, Van Raaij JAGM, Van den Berg KJ, Tjong Tjin Joe C, Van Engelen JGM, Brouwer A: Glucuronidation of thyroid hormone in rat liver: effects of in vivo treatment with microsomal enzyme inducers and in vitro assay conditions. Endocrinology 1993;133:2177-2186.
69. Visser TJ, Kaptein E, Harpur ES: Differential expression and ciprofibrate induction of hepatic UDP-glucuronyltransferases for thyroxine and triiodothyronine in Fischer rats. Biochem Pharmacol 1991;42:444-446.
70. Visser TJ, Kaptein E, Van Raaij, JAGM, Tjong Tjin Joe C, Ebner T, Burchell B: Multiple UDP-glucuronyltransferases for the glucuronidation of thyroid hormone with preference for 3,3′,5′-triiodothyronine (reverse T3). FEBS Lett 1993;315:65-68.
71. Emi Y, Ikushiro SI, Iyanagi T: Drug-responsive and tissue-specific alternative expression of multiple first exons in rat UDP-glucuronosyltransferase family 1 (UGT1) gene complex. J Biochem 1995;117:392-399.
72. Homma H, Kawai H, Kubota M, Matsui M: Large deletion of androsterone UDP-glucuronosyltransferase gene in the inherited deficient strain of Wistar rats. Biochim Biophys Acta 1992;1138:34-40.
73. Visser TJ, Kaptein E, Gijzel AL, De Herder WW, Ebner T, Burchell B: Glucuronidation of thyroid hormone by human bilirubin and phenol UDP-glucuronyltransferase isoenzymes. FEBS Lett 1993;324:358-360.
74. Roy Chowdhury J, Roy Chowdhury N, Moscioni AD, Tukey R, Tephley TR, Arias IM: Differential regulation by triiodothyronine of substrate-specific uridinediphosphoglucuronate glucuronosyl transfereases in rat liver. Biochim Biophys Acta 1983;761:58-65.
75. Van Steenbergen W, Fevery J, De Vos R, Leyten R, Heirwegh KPM, De Groote J: Thyroid hormones and the hepatic handling of bilirubin. I. Effects of hypothyroidism and hyperthyroidism on the hepatic transport of bilirubin monoand diconjugates in the Wistar rat. Hepatology 1989;9:314-321.
76. Masmoudi T, Planells R, Mounie J, Artur Y, Magdalou J, Goudonnet H: Opposite regulation of bilirubin and 4-nitrophenol UDP-glucuronosyltransferase mRNA levels by 3,3′,5-triiodo-L-thyronine in rat liver FEBS Lett 1996;379:181-185.
77. Owens IS, Ritter JK: The novel bilirubin/phenol UDP-glucuronosyltransferase UGT1 gene locus: implications for multiple nonhemolytic familial hyperbilirubinemia phenotypes. Pharmacogenetics 1992;2:93-108.
78. Visser TJ, Kaptein E, Gijzel A, de Herder WW, Cannon ML, Bonthuis F, de Greef WJ: Effects of thyroid status and thyrostatic drugs on hepatic glucuronidation of iodothyronines and other substrates in rats. Induction of phenol UDP-glucuronyltransferase by methimazole. Endocrine 1996;4:79-85.
79. Moreno M, Kaptein E, Goglia F, Visser TJ: Rapid glucuronidation of tri-and tetraiodothyroacetic acid to ester glucuronides in human liver and to ether glucuronides in rat liver. Endocrinology 1994;135:1004-1009.
80. Spahn-Langguth H, Benet LZ: Acyl glucuronides revisited: is the glucuronidation process a toxification as well as a detoxification mechanism? Drug Metab Rev 1992;24:5-48.
81. Visser TJ, Fekkes D, Docter R, Hennemann G: Kinetics of enzymic reductive deiodination of iodothyronines. Biochem J 1979;179:489-495.
82. Visser TJ, Leonard JL, Kaplan MM, Larsen PR: Kinetic evidence suggesting two mechanisms for iodothyronine 5′-deiodination in rat cerebral cortex. Proc Natl Acad Sci USA 1982;79:5080-5084.
83. Kaplan MM, Visser TJ, Yaskoski KA, Leonard JL: Characteristics of iodothyronine tyrosyl ring deiodination by rat cerebral cortical microsomes. Endocrinology 1983;112:35-42.